Global AI-Designed Small-Molecule Drugs Supply, Demand and Key Producers, 2026-2032
The global AI-Designed Small-Molecule Drugs market size is expected to reach $ 6010 million by 2032, rising at a market growth of 24.2% CAGR during the forecast period (2026-2032).
AI-designed small-molecule drugs are synthesizable and developable drug candidates for which machine learning, generative AI, and physics-based modeling make a material contribution to target identification, virtual screening, molecular generation, structure?activity optimization, or ADMET prediction. They are supplied as discovery-stage molecules, preclinical candidates, clinical pipeline assets, or licensed programs and are evaluated by target novelty, potency and selectivity, oral exposure, tissue distribution, safety margin, manufacturability, and intellectual property. Major uses include oncology, immunology and inflammation, neurology, metabolic disease, and infectious disease research. The market scope covers related R&D spending, collaboration revenue, upfront licensing payments, and milestone value rather than end-market prescription drug sales, with an estimated blended gross margin of about 68%.
Demand is driven by pharmaceutical companies seeking to shorten early discovery cycles, expand the range of druggable targets, and improve the quality of candidates entering clinical development. Oncology, immunology and inflammation, neurology, and metabolic diseases are the first areas to build dense AI-enabled pipelines because they combine substantial unmet need with increasingly rich target and molecular data. Demand is particularly strong for oral therapies, brain-penetrant compounds, mutation-selective inhibitors, and programs against historically difficult targets.
Competition is moving beyond stand-alone virtual screening toward closed loops that connect target discovery, generative design, automated synthesis, experimental validation, and clinical translation. Leading suppliers are building proprietary datasets, physics-based simulation, foundation models, and wet-lab infrastructure while validating their systems through internal pipelines and pharmaceutical partnerships. Product development is advancing toward simultaneous multiparameter optimization, more reliable selectivity and toxicity prediction, protein dynamics modeling, active learning, and exploration of new chemical space for protein degradation and nucleic-acid targets.
North America continues to concentrate most AI-native drug developers, capital, and large-pharma partnerships, while the United Kingdom, France, and China are building differentiated capabilities in generative chemistry, structure prediction, laboratory automation, and clinical execution. Customers increasingly evaluate suppliers by delivered candidates, clinical milestones, data feedback loops, and intellectual-property boundaries rather than model benchmarks alone. Key risks include long clinical validation cycles, biased training data, limited synthetic feasibility, and complex ownership of partnered assets. Companies with end-to-end development capability, repeatable delivery records, and cross-regional clinical resources are better positioned to secure licensing and co-development opportunities.
Report Scope
This report studies the global AI-Designed Small-Molecule Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for AI-Designed Small-Molecule Drugs and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of AI-Designed Small-Molecule Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global AI-Designed Small-Molecule Drugs total production and demand, 2021-2032, (K Dose)
Global AI-Designed Small-Molecule Drugs total production value, 2021-2032, (USD Million)
Global AI-Designed Small-Molecule Drugs production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
Global AI-Designed Small-Molecule Drugs consumption by region & country, CAGR, 2021-2032 & (K Dose)
U.S. VS China: AI-Designed Small-Molecule Drugs domestic production, consumption, key domestic manufacturers and share
Global AI-Designed Small-Molecule Drugs production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
Global AI-Designed Small-Molecule Drugs production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
Global AI-Designed Small-Molecule Drugs production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report profiles key players in the global AI-Designed Small-Molecule Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Recursion Pharmaceuticals, Insilico Medicine, Schr?dinger, XtalPi, Isomorphic Labs, Relay Therapeutics, Nimbus Therapeutics, Iambic Therapeutics, BenevolentAI, Accutar Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World AI-Designed Small-Molecule Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global AI-Designed Small-Molecule Drugs Market, By Region:
1. How big is the global AI-Designed Small-Molecule Drugs market?
2. What is the demand of the global AI-Designed Small-Molecule Drugs market?
3. What is the year over year growth of the global AI-Designed Small-Molecule Drugs market?
4. What is the production and production value of the global AI-Designed Small-Molecule Drugs market?
5. Who are the key producers in the global AI-Designed Small-Molecule Drugs market?
6. What are the growth factors driving the market demand?
AI-designed small-molecule drugs are synthesizable and developable drug candidates for which machine learning, generative AI, and physics-based modeling make a material contribution to target identification, virtual screening, molecular generation, structure?activity optimization, or ADMET prediction. They are supplied as discovery-stage molecules, preclinical candidates, clinical pipeline assets, or licensed programs and are evaluated by target novelty, potency and selectivity, oral exposure, tissue distribution, safety margin, manufacturability, and intellectual property. Major uses include oncology, immunology and inflammation, neurology, metabolic disease, and infectious disease research. The market scope covers related R&D spending, collaboration revenue, upfront licensing payments, and milestone value rather than end-market prescription drug sales, with an estimated blended gross margin of about 68%.
Demand is driven by pharmaceutical companies seeking to shorten early discovery cycles, expand the range of druggable targets, and improve the quality of candidates entering clinical development. Oncology, immunology and inflammation, neurology, and metabolic diseases are the first areas to build dense AI-enabled pipelines because they combine substantial unmet need with increasingly rich target and molecular data. Demand is particularly strong for oral therapies, brain-penetrant compounds, mutation-selective inhibitors, and programs against historically difficult targets.
Competition is moving beyond stand-alone virtual screening toward closed loops that connect target discovery, generative design, automated synthesis, experimental validation, and clinical translation. Leading suppliers are building proprietary datasets, physics-based simulation, foundation models, and wet-lab infrastructure while validating their systems through internal pipelines and pharmaceutical partnerships. Product development is advancing toward simultaneous multiparameter optimization, more reliable selectivity and toxicity prediction, protein dynamics modeling, active learning, and exploration of new chemical space for protein degradation and nucleic-acid targets.
North America continues to concentrate most AI-native drug developers, capital, and large-pharma partnerships, while the United Kingdom, France, and China are building differentiated capabilities in generative chemistry, structure prediction, laboratory automation, and clinical execution. Customers increasingly evaluate suppliers by delivered candidates, clinical milestones, data feedback loops, and intellectual-property boundaries rather than model benchmarks alone. Key risks include long clinical validation cycles, biased training data, limited synthetic feasibility, and complex ownership of partnered assets. Companies with end-to-end development capability, repeatable delivery records, and cross-regional clinical resources are better positioned to secure licensing and co-development opportunities.
Report Scope
This report studies the global AI-Designed Small-Molecule Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for AI-Designed Small-Molecule Drugs and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of AI-Designed Small-Molecule Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global AI-Designed Small-Molecule Drugs total production and demand, 2021-2032, (K Dose)
Global AI-Designed Small-Molecule Drugs total production value, 2021-2032, (USD Million)
Global AI-Designed Small-Molecule Drugs production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Dose), (based on production site)
Global AI-Designed Small-Molecule Drugs consumption by region & country, CAGR, 2021-2032 & (K Dose)
U.S. VS China: AI-Designed Small-Molecule Drugs domestic production, consumption, key domestic manufacturers and share
Global AI-Designed Small-Molecule Drugs production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Dose)
Global AI-Designed Small-Molecule Drugs production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
Global AI-Designed Small-Molecule Drugs production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Dose)
This report profiles key players in the global AI-Designed Small-Molecule Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Recursion Pharmaceuticals, Insilico Medicine, Schr?dinger, XtalPi, Isomorphic Labs, Relay Therapeutics, Nimbus Therapeutics, Iambic Therapeutics, BenevolentAI, Accutar Biotechnology, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World AI-Designed Small-Molecule Drugs market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global AI-Designed Small-Molecule Drugs Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Discovery-Stage Candidates
- Preclinical Candidates
- Clinical-Stage Candidates
- Approved Drugs
- Enzyme Inhibitors
- Receptor Agonists
- Receptor Antagonists
- Targeted Protein Degraders
- Molecular Glues
- Other Small-Molecule Modulators
- Oral Drugs
- Injectable Drugs
- Inhaled Drugs
- Topical Drugs
- Other Administration Routes
- Kinases
- Other Enzymes
- G Protein-Coupled Receptors
- Nuclear Receptors
- Protein?Protein Interaction Targets
- Nucleic Acid Targets
- Other Target Classes
- Oncology
- Immunology and Inflammation
- Neurology and Psychiatry
- Metabolic and Cardiovascular Diseases
- Infectious Diseases
- Other Therapeutic Areas
- Recursion Pharmaceuticals
- Insilico Medicine
- Schr?dinger
- XtalPi
- Isomorphic Labs
- Relay Therapeutics
- Nimbus Therapeutics
- Iambic Therapeutics
- BenevolentAI
- Accutar Biotechnology
- MindRank AI
- Enveda Biosciences
- Insitro
- Valo Health
- Healx
- Lantern Pharma
- Verge Labs
- DeepCure
- AQEMIA
- Genesis Molecular AI
- Terray Therapeutics
- CHARM Therapeutics
- Anagenex
- StoneWise
1. How big is the global AI-Designed Small-Molecule Drugs market?
2. What is the demand of the global AI-Designed Small-Molecule Drugs market?
3. What is the year over year growth of the global AI-Designed Small-Molecule Drugs market?
4. What is the production and production value of the global AI-Designed Small-Molecule Drugs market?
5. Who are the key producers in the global AI-Designed Small-Molecule Drugs market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 AI-Designed Small-Molecule Drugs Introduction
1.2 World AI-Designed Small-Molecule Drugs Supply & Forecast
1.2.1 World AI-Designed Small-Molecule Drugs Production Value (2021 & 2025 & 2032)
1.2.2 World AI-Designed Small-Molecule Drugs Production (2021-2032)
1.2.3 World AI-Designed Small-Molecule Drugs Pricing Trends (2021-2032)
1.3 World AI-Designed Small-Molecule Drugs Production by Region (Based on Production Site)
1.3.1 World AI-Designed Small-Molecule Drugs Production Value by Region (2021-2032)
1.3.2 World AI-Designed Small-Molecule Drugs Production by Region (2021-2032)
1.3.3 World AI-Designed Small-Molecule Drugs Average Price by Region (2021-2032)
1.3.4 North America AI-Designed Small-Molecule Drugs Production (2021-2032)
1.3.5 Europe AI-Designed Small-Molecule Drugs Production (2021-2032)
1.3.6 China AI-Designed Small-Molecule Drugs Production (2021-2032)
1.3.7 Japan AI-Designed Small-Molecule Drugs Production (2021-2032)
1.3.8 India AI-Designed Small-Molecule Drugs Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 AI-Designed Small-Molecule Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 AI-Designed Small-Molecule Drugs Major Market Trends
2 DEMAND SUMMARY
2.1 World AI-Designed Small-Molecule Drugs Demand (2021-2032)
2.2 World AI-Designed Small-Molecule Drugs Consumption by Region
2.2.1 World AI-Designed Small-Molecule Drugs Consumption by Region (2021-2026)
2.2.2 World AI-Designed Small-Molecule Drugs Consumption Forecast by Region (2027-2032)
2.3 United States AI-Designed Small-Molecule Drugs Consumption (2021-2032)
2.4 China AI-Designed Small-Molecule Drugs Consumption (2021-2032)
2.5 Europe AI-Designed Small-Molecule Drugs Consumption (2021-2032)
2.6 Japan AI-Designed Small-Molecule Drugs Consumption (2021-2032)
2.7 South Korea AI-Designed Small-Molecule Drugs Consumption (2021-2032)
2.8 ASEAN AI-Designed Small-Molecule Drugs Consumption (2021-2032)
2.9 India AI-Designed Small-Molecule Drugs Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World AI-Designed Small-Molecule Drugs Production Value by Manufacturer (2021-2026)
3.2 World AI-Designed Small-Molecule Drugs Production by Manufacturer (2021-2026)
3.3 World AI-Designed Small-Molecule Drugs Average Price by Manufacturer (2021-2026)
3.4 AI-Designed Small-Molecule Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global AI-Designed Small-Molecule Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for AI-Designed Small-Molecule Drugs in 2025
3.5.3 Global Concentration Ratios (CR8) for AI-Designed Small-Molecule Drugs in 2025
3.6 AI-Designed Small-Molecule Drugs Market: Overall Company Footprint Analysis
3.6.1 AI-Designed Small-Molecule Drugs Market: Region Footprint
3.6.2 AI-Designed Small-Molecule Drugs Market: Company Product Type Footprint
3.6.3 AI-Designed Small-Molecule Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: AI-Designed Small-Molecule Drugs Production Value Comparison
4.1.1 United States VS China: AI-Designed Small-Molecule Drugs Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: AI-Designed Small-Molecule Drugs Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: AI-Designed Small-Molecule Drugs Production Comparison
4.2.1 United States VS China: AI-Designed Small-Molecule Drugs Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: AI-Designed Small-Molecule Drugs Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: AI-Designed Small-Molecule Drugs Consumption Comparison
4.3.1 United States VS China: AI-Designed Small-Molecule Drugs Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: AI-Designed Small-Molecule Drugs Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based AI-Designed Small-Molecule Drugs Manufacturers and Market Share, 2021-2026
4.4.1 United States Based AI-Designed Small-Molecule Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers AI-Designed Small-Molecule Drugs Production Value (2021-2026)
4.4.3 United States Based Manufacturers AI-Designed Small-Molecule Drugs Production (2021-2026)
4.5 China Based AI-Designed Small-Molecule Drugs Manufacturers and Market Share
4.5.1 China Based AI-Designed Small-Molecule Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers AI-Designed Small-Molecule Drugs Production Value (2021-2026)
4.5.3 China Based Manufacturers AI-Designed Small-Molecule Drugs Production (2021-2026)
4.6 Rest of World Based AI-Designed Small-Molecule Drugs Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based AI-Designed Small-Molecule Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers AI-Designed Small-Molecule Drugs Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers AI-Designed Small-Molecule Drugs Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World AI-Designed Small-Molecule Drugs Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Discovery-Stage Candidates
5.2.2 Preclinical Candidates
5.2.3 Clinical-Stage Candidates
5.2.4 Approved Drugs
5.3 Market Segment by Type
5.3.1 World AI-Designed Small-Molecule Drugs Production by Type (2021-2032)
5.3.2 World AI-Designed Small-Molecule Drugs Production Value by Type (2021-2032)
5.3.3 World AI-Designed Small-Molecule Drugs Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY MECHANISM OF ACTION
6.1 World AI-Designed Small-Molecule Drugs Market Size Overview by Mechanism of Action: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Mechanism of Action
6.2.1 Enzyme Inhibitors
6.2.2 Receptor Agonists
6.2.3 Receptor Antagonists
6.2.4 Targeted Protein Degraders
6.2.5 Molecular Glues
6.2.6 Other Small-Molecule Modulators
6.3 Market Segment by Mechanism of Action
6.3.1 World AI-Designed Small-Molecule Drugs Production by Mechanism of Action (2021-2032)
6.3.2 World AI-Designed Small-Molecule Drugs Production Value by Mechanism of Action (2021-2032)
6.3.3 World AI-Designed Small-Molecule Drugs Average Price by Mechanism of Action (2021-2032)
7 MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
7.1 World AI-Designed Small-Molecule Drugs Market Size Overview by Route of Administration: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Route of Administration
7.2.1 Oral Drugs
7.2.2 Injectable Drugs
7.2.3 Inhaled Drugs
7.2.4 Topical Drugs
7.2.5 Other Administration Routes
7.3 Market Segment by Route of Administration
7.3.1 World AI-Designed Small-Molecule Drugs Production by Route of Administration (2021-2032)
7.3.2 World AI-Designed Small-Molecule Drugs Production Value by Route of Administration (2021-2032)
7.3.3 World AI-Designed Small-Molecule Drugs Average Price by Route of Administration (2021-2032)
8 MARKET ANALYSIS BY TARGET CLASS
8.1 World AI-Designed Small-Molecule Drugs Market Size Overview by Target Class: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Target Class
8.2.1 Kinases
8.2.2 Other Enzymes
8.2.3 G Protein-Coupled Receptors
8.2.4 Nuclear Receptors
8.2.5 Protein?Protein Interaction Targets
8.2.6 Nucleic Acid Targets
8.2.7 Other Target Classes
8.3 Market Segment by Target Class
8.3.1 World AI-Designed Small-Molecule Drugs Production by Target Class (2021-2032)
8.3.2 World AI-Designed Small-Molecule Drugs Production Value by Target Class (2021-2032)
8.3.3 World AI-Designed Small-Molecule Drugs Average Price by Target Class (2021-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World AI-Designed Small-Molecule Drugs Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Oncology
9.2.2 Immunology and Inflammation
9.2.3 Neurology and Psychiatry
9.2.4 Metabolic and Cardiovascular Diseases
9.2.5 Infectious Diseases
9.2.6 Other Therapeutic Areas
9.3 Market Segment by Application
9.3.1 World AI-Designed Small-Molecule Drugs Production by Application (2021-2032)
9.3.2 World AI-Designed Small-Molecule Drugs Production Value by Application (2021-2032)
9.3.3 World AI-Designed Small-Molecule Drugs Average Price by Application (2021-2032)
10 COMPANY PROFILES
10.1 Recursion Pharmaceuticals
10.1.1 Recursion Pharmaceuticals Details
10.1.2 Recursion Pharmaceuticals Major Business
10.1.3 Recursion Pharmaceuticals AI-Designed Small-Molecule Drugs Product and Services
10.1.4 Recursion Pharmaceuticals AI-Designed Small-Molecule Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.1.5 Recursion Pharmaceuticals Recent Developments/Updates
10.1.6 Recursion Pharmaceuticals Competitive Strengths & Weaknesses
10.2 Insilico Medicine
10.2.1 Insilico Medicine Details
10.2.2 Insilico Medicine Major Business
10.2.3 Insilico Medicine AI-Designed Small-Molecule Drugs Product and Services
10.2.4 Insilico Medicine AI-Designed Small-Molecule Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.2.5 Insilico Medicine Recent Developments/Updates
10.2.6 Insilico Medicine Competitive Strengths & Weaknesses
10.3 Schr?dinger
10.3.1 Schr?dinger Details
10.3.2 Schr?dinger Major Business
10.3.3 Schr?dinger AI-Designed Small-Molecule Drugs Product and Services
10.3.4 Schr?dinger AI-Designed Small-Molecule Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.3.5 Schr?dinger Recent Developments/Updates
10.3.6 Schr?dinger Competitive Strengths & Weaknesses
10.4 XtalPi
10.4.1 XtalPi Details
10.4.2 XtalPi Major Business
10.4.3 XtalPi AI-Designed Small-Molecule Drugs Product and Services
10.4.4 XtalPi AI-Designed Small-Molecule Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.4.5 XtalPi Recent Developments/Updates
10.4.6 XtalPi Competitive Strengths & Weaknesses
10.5 Isomorphic Labs
10.5.1 Isomorphic Labs Details
10.5.2 Isomorphic Labs Major Business
10.5.3 Isomorphic Labs AI-Designed Small-Molecule Drugs Product and Services
10.5.4 Isomorphic Labs AI-Designed Small-Molecule Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.5.5 Isomorphic Labs Recent Developments/Updates
10.5.6 Isomorphic Labs Competitive Strengths & Weaknesses
10.6 Relay Therapeutics
10.6.1 Relay Therapeutics Details
10.6.2 Relay Therapeutics Major Business
10.6.3 Relay Therapeutics AI-Designed Small-Molecule Drugs Product and Services
10.6.4 Relay Therapeutics AI-Designed Small-Molecule Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.6.5 Relay Therapeutics Recent Developments/Updates
10.6.6 Relay Therapeutics Competitive Strengths & Weaknesses
10.7 Nimbus Therapeutics
10.7.1 Nimbus Therapeutics Details
10.7.2 Nimbus Therapeutics Major Business
10.7.3 Nimbus Therapeutics AI-Designed Small-Molecule Drugs Product and Services
10.7.4 Nimbus Therapeutics AI-Designed Small-Molecule Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.7.5 Nimbus Therapeutics Recent Developments/Updates
10.7.6 Nimbus Therapeutics Competitive Strengths & Weaknesses
10.8 Iambic Therapeutics
10.8.1 Iambic Therapeutics Details
10.8.2 Iambic Therapeutics Major Business
10.8.3 Iambic Therapeutics AI-Designed Small-Molecule Drugs Product and Services
10.8.4 Iambic Therapeutics AI-Designed Small-Molecule Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.8.5 Iambic Therapeutics Recent Developments/Updates
10.8.6 Iambic Therapeutics Competitive Strengths & Weaknesses
10.9 BenevolentAI
10.9.1 BenevolentAI Details
10.9.2 BenevolentAI Major Business
10.9.3 BenevolentAI AI-Designed Small-Molecule Drugs Product and Services
10.9.4 BenevolentAI AI-Designed Small-Molecule Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.9.5 BenevolentAI Recent Developments/Updates
10.9.6 BenevolentAI Competitive Strengths & Weaknesses
10.10 Accutar Biotechnology
10.10.1 Accutar Biotechnology Details
10.10.2 Accutar Biotechnology Major Business
10.10.3 Accutar Biotechnology AI-Designed Small-Molecule Drugs Product and Services
10.10.4 Accutar Biotechnology AI-Designed Small-Molecule Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.10.5 Accutar Biotechnology Recent Developments/Updates
10.10.6 Accutar Biotechnology Competitive Strengths & Weaknesses
10.11 MindRank AI
10.11.1 MindRank AI Details
10.11.2 MindRank AI Major Business
10.11.3 MindRank AI AI-Designed Small-Molecule Drugs Product and Services
10.11.4 MindRank AI AI-Designed Small-Molecule Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.11.5 MindRank AI Recent Developments/Updates
10.11.6 MindRank AI Competitive Strengths & Weaknesses
10.12 Enveda Biosciences
10.12.1 Enveda Biosciences Details
10.12.2 Enveda Biosciences Major Business
10.12.3 Enveda Biosciences AI-Designed Small-Molecule Drugs Product and Services
10.12.4 Enveda Biosciences AI-Designed Small-Molecule Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.12.5 Enveda Biosciences Recent Developments/Updates
10.12.6 Enveda Biosciences Competitive Strengths & Weaknesses
10.13 Insitro
10.13.1 Insitro Details
10.13.2 Insitro Major Business
10.13.3 Insitro AI-Designed Small-Molecule Drugs Product and Services
10.13.4 Insitro AI-Designed Small-Molecule Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.13.5 Insitro Recent Developments/Updates
10.13.6 Insitro Competitive Strengths & Weaknesses
10.14 Valo Health
10.14.1 Valo Health Details
10.14.2 Valo Health Major Business
10.14.3 Valo Health AI-Designed Small-Molecule Drugs Product and Services
10.14.4 Valo Health AI-Designed Small-Molecule Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.14.5 Valo Health Recent Developments/Updates
10.14.6 Valo Health Competitive Strengths & Weaknesses
10.15 Healx
10.15.1 Healx Details
10.15.2 Healx Major Business
10.15.3 Healx AI-Designed Small-Molecule Drugs Product and Services
10.15.4 Healx AI-Designed Small-Molecule Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.15.5 Healx Recent Developments/Updates
10.15.6 Healx Competitive Strengths & Weaknesses
10.16 Lantern Pharma
10.16.1 Lantern Pharma Details
10.16.2 Lantern Pharma Major Business
10.16.3 Lantern Pharma AI-Designed Small-Molecule Drugs Product and Services
10.16.4 Lantern Pharma AI-Designed Small-Molecule Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.16.5 Lantern Pharma Recent Developments/Updates
10.16.6 Lantern Pharma Competitive Strengths & Weaknesses
10.17 Verge Labs
10.17.1 Verge Labs Details
10.17.2 Verge Labs Major Business
10.17.3 Verge Labs AI-Designed Small-Molecule Drugs Product and Services
10.17.4 Verge Labs AI-Designed Small-Molecule Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.17.5 Verge Labs Recent Developments/Updates
10.17.6 Verge Labs Competitive Strengths & Weaknesses
10.18 DeepCure
10.18.1 DeepCure Details
10.18.2 DeepCure Major Business
10.18.3 DeepCure AI-Designed Small-Molecule Drugs Product and Services
10.18.4 DeepCure AI-Designed Small-Molecule Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.18.5 DeepCure Recent Developments/Updates
10.18.6 DeepCure Competitive Strengths & Weaknesses
10.19 AQEMIA
10.19.1 AQEMIA Details
10.19.2 AQEMIA Major Business
10.19.3 AQEMIA AI-Designed Small-Molecule Drugs Product and Services
10.19.4 AQEMIA AI-Designed Small-Molecule Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.19.5 AQEMIA Recent Developments/Updates
10.19.6 AQEMIA Competitive Strengths & Weaknesses
10.20 Genesis Molecular AI
10.20.1 Genesis Molecular AI Details
10.20.2 Genesis Molecular AI Major Business
10.20.3 Genesis Molecular AI AI-Designed Small-Molecule Drugs Product and Services
10.20.4 Genesis Molecular AI AI-Designed Small-Molecule Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.20.5 Genesis Molecular AI Recent Developments/Updates
10.20.6 Genesis Molecular AI Competitive Strengths & Weaknesses
10.21 Terray Therapeutics
10.21.1 Terray Therapeutics Details
10.21.2 Terray Therapeutics Major Business
10.21.3 Terray Therapeutics AI-Designed Small-Molecule Drugs Product and Services
10.21.4 Terray Therapeutics AI-Designed Small-Molecule Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.21.5 Terray Therapeutics Recent Developments/Updates
10.21.6 Terray Therapeutics Competitive Strengths & Weaknesses
10.22 CHARM Therapeutics
10.22.1 CHARM Therapeutics Details
10.22.2 CHARM Therapeutics Major Business
10.22.3 CHARM Therapeutics AI-Designed Small-Molecule Drugs Product and Services
10.22.4 CHARM Therapeutics AI-Designed Small-Molecule Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.22.5 CHARM Therapeutics Recent Developments/Updates
10.22.6 CHARM Therapeutics Competitive Strengths & Weaknesses
10.23 Anagenex
10.23.1 Anagenex Details
10.23.2 Anagenex Major Business
10.23.3 Anagenex AI-Designed Small-Molecule Drugs Product and Services
10.23.4 Anagenex AI-Designed Small-Molecule Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.23.5 Anagenex Recent Developments/Updates
10.23.6 Anagenex Competitive Strengths & Weaknesses
10.24 StoneWise
10.24.1 StoneWise Details
10.24.2 StoneWise Major Business
10.24.3 StoneWise AI-Designed Small-Molecule Drugs Product and Services
10.24.4 StoneWise AI-Designed Small-Molecule Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.24.5 StoneWise Recent Developments/Updates
10.24.6 StoneWise Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 AI-Designed Small-Molecule Drugs Industry Chain
11.2 AI-Designed Small-Molecule Drugs Upstream Analysis
11.2.1 AI-Designed Small-Molecule Drugs Core Raw Materials
11.2.2 Main Manufacturers of AI-Designed Small-Molecule Drugs Core Raw Materials
11.3 Midstream Analysis
11.4 Downstream Analysis
11.5 AI-Designed Small-Molecule Drugs Production Mode
11.6 AI-Designed Small-Molecule Drugs Procurement Model
11.7 AI-Designed Small-Molecule Drugs Industry Sales Model and Sales Channels
11.7.1 AI-Designed Small-Molecule Drugs Sales Model
11.7.2 AI-Designed Small-Molecule Drugs Typical Distributors
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
1.1 AI-Designed Small-Molecule Drugs Introduction
1.2 World AI-Designed Small-Molecule Drugs Supply & Forecast
1.2.1 World AI-Designed Small-Molecule Drugs Production Value (2021 & 2025 & 2032)
1.2.2 World AI-Designed Small-Molecule Drugs Production (2021-2032)
1.2.3 World AI-Designed Small-Molecule Drugs Pricing Trends (2021-2032)
1.3 World AI-Designed Small-Molecule Drugs Production by Region (Based on Production Site)
1.3.1 World AI-Designed Small-Molecule Drugs Production Value by Region (2021-2032)
1.3.2 World AI-Designed Small-Molecule Drugs Production by Region (2021-2032)
1.3.3 World AI-Designed Small-Molecule Drugs Average Price by Region (2021-2032)
1.3.4 North America AI-Designed Small-Molecule Drugs Production (2021-2032)
1.3.5 Europe AI-Designed Small-Molecule Drugs Production (2021-2032)
1.3.6 China AI-Designed Small-Molecule Drugs Production (2021-2032)
1.3.7 Japan AI-Designed Small-Molecule Drugs Production (2021-2032)
1.3.8 India AI-Designed Small-Molecule Drugs Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 AI-Designed Small-Molecule Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 AI-Designed Small-Molecule Drugs Major Market Trends
2 DEMAND SUMMARY
2.1 World AI-Designed Small-Molecule Drugs Demand (2021-2032)
2.2 World AI-Designed Small-Molecule Drugs Consumption by Region
2.2.1 World AI-Designed Small-Molecule Drugs Consumption by Region (2021-2026)
2.2.2 World AI-Designed Small-Molecule Drugs Consumption Forecast by Region (2027-2032)
2.3 United States AI-Designed Small-Molecule Drugs Consumption (2021-2032)
2.4 China AI-Designed Small-Molecule Drugs Consumption (2021-2032)
2.5 Europe AI-Designed Small-Molecule Drugs Consumption (2021-2032)
2.6 Japan AI-Designed Small-Molecule Drugs Consumption (2021-2032)
2.7 South Korea AI-Designed Small-Molecule Drugs Consumption (2021-2032)
2.8 ASEAN AI-Designed Small-Molecule Drugs Consumption (2021-2032)
2.9 India AI-Designed Small-Molecule Drugs Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World AI-Designed Small-Molecule Drugs Production Value by Manufacturer (2021-2026)
3.2 World AI-Designed Small-Molecule Drugs Production by Manufacturer (2021-2026)
3.3 World AI-Designed Small-Molecule Drugs Average Price by Manufacturer (2021-2026)
3.4 AI-Designed Small-Molecule Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global AI-Designed Small-Molecule Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for AI-Designed Small-Molecule Drugs in 2025
3.5.3 Global Concentration Ratios (CR8) for AI-Designed Small-Molecule Drugs in 2025
3.6 AI-Designed Small-Molecule Drugs Market: Overall Company Footprint Analysis
3.6.1 AI-Designed Small-Molecule Drugs Market: Region Footprint
3.6.2 AI-Designed Small-Molecule Drugs Market: Company Product Type Footprint
3.6.3 AI-Designed Small-Molecule Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: AI-Designed Small-Molecule Drugs Production Value Comparison
4.1.1 United States VS China: AI-Designed Small-Molecule Drugs Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: AI-Designed Small-Molecule Drugs Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: AI-Designed Small-Molecule Drugs Production Comparison
4.2.1 United States VS China: AI-Designed Small-Molecule Drugs Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: AI-Designed Small-Molecule Drugs Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: AI-Designed Small-Molecule Drugs Consumption Comparison
4.3.1 United States VS China: AI-Designed Small-Molecule Drugs Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: AI-Designed Small-Molecule Drugs Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based AI-Designed Small-Molecule Drugs Manufacturers and Market Share, 2021-2026
4.4.1 United States Based AI-Designed Small-Molecule Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers AI-Designed Small-Molecule Drugs Production Value (2021-2026)
4.4.3 United States Based Manufacturers AI-Designed Small-Molecule Drugs Production (2021-2026)
4.5 China Based AI-Designed Small-Molecule Drugs Manufacturers and Market Share
4.5.1 China Based AI-Designed Small-Molecule Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers AI-Designed Small-Molecule Drugs Production Value (2021-2026)
4.5.3 China Based Manufacturers AI-Designed Small-Molecule Drugs Production (2021-2026)
4.6 Rest of World Based AI-Designed Small-Molecule Drugs Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based AI-Designed Small-Molecule Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers AI-Designed Small-Molecule Drugs Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers AI-Designed Small-Molecule Drugs Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World AI-Designed Small-Molecule Drugs Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Discovery-Stage Candidates
5.2.2 Preclinical Candidates
5.2.3 Clinical-Stage Candidates
5.2.4 Approved Drugs
5.3 Market Segment by Type
5.3.1 World AI-Designed Small-Molecule Drugs Production by Type (2021-2032)
5.3.2 World AI-Designed Small-Molecule Drugs Production Value by Type (2021-2032)
5.3.3 World AI-Designed Small-Molecule Drugs Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY MECHANISM OF ACTION
6.1 World AI-Designed Small-Molecule Drugs Market Size Overview by Mechanism of Action: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Mechanism of Action
6.2.1 Enzyme Inhibitors
6.2.2 Receptor Agonists
6.2.3 Receptor Antagonists
6.2.4 Targeted Protein Degraders
6.2.5 Molecular Glues
6.2.6 Other Small-Molecule Modulators
6.3 Market Segment by Mechanism of Action
6.3.1 World AI-Designed Small-Molecule Drugs Production by Mechanism of Action (2021-2032)
6.3.2 World AI-Designed Small-Molecule Drugs Production Value by Mechanism of Action (2021-2032)
6.3.3 World AI-Designed Small-Molecule Drugs Average Price by Mechanism of Action (2021-2032)
7 MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
7.1 World AI-Designed Small-Molecule Drugs Market Size Overview by Route of Administration: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Route of Administration
7.2.1 Oral Drugs
7.2.2 Injectable Drugs
7.2.3 Inhaled Drugs
7.2.4 Topical Drugs
7.2.5 Other Administration Routes
7.3 Market Segment by Route of Administration
7.3.1 World AI-Designed Small-Molecule Drugs Production by Route of Administration (2021-2032)
7.3.2 World AI-Designed Small-Molecule Drugs Production Value by Route of Administration (2021-2032)
7.3.3 World AI-Designed Small-Molecule Drugs Average Price by Route of Administration (2021-2032)
8 MARKET ANALYSIS BY TARGET CLASS
8.1 World AI-Designed Small-Molecule Drugs Market Size Overview by Target Class: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Target Class
8.2.1 Kinases
8.2.2 Other Enzymes
8.2.3 G Protein-Coupled Receptors
8.2.4 Nuclear Receptors
8.2.5 Protein?Protein Interaction Targets
8.2.6 Nucleic Acid Targets
8.2.7 Other Target Classes
8.3 Market Segment by Target Class
8.3.1 World AI-Designed Small-Molecule Drugs Production by Target Class (2021-2032)
8.3.2 World AI-Designed Small-Molecule Drugs Production Value by Target Class (2021-2032)
8.3.3 World AI-Designed Small-Molecule Drugs Average Price by Target Class (2021-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World AI-Designed Small-Molecule Drugs Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 Oncology
9.2.2 Immunology and Inflammation
9.2.3 Neurology and Psychiatry
9.2.4 Metabolic and Cardiovascular Diseases
9.2.5 Infectious Diseases
9.2.6 Other Therapeutic Areas
9.3 Market Segment by Application
9.3.1 World AI-Designed Small-Molecule Drugs Production by Application (2021-2032)
9.3.2 World AI-Designed Small-Molecule Drugs Production Value by Application (2021-2032)
9.3.3 World AI-Designed Small-Molecule Drugs Average Price by Application (2021-2032)
10 COMPANY PROFILES
10.1 Recursion Pharmaceuticals
10.1.1 Recursion Pharmaceuticals Details
10.1.2 Recursion Pharmaceuticals Major Business
10.1.3 Recursion Pharmaceuticals AI-Designed Small-Molecule Drugs Product and Services
10.1.4 Recursion Pharmaceuticals AI-Designed Small-Molecule Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.1.5 Recursion Pharmaceuticals Recent Developments/Updates
10.1.6 Recursion Pharmaceuticals Competitive Strengths & Weaknesses
10.2 Insilico Medicine
10.2.1 Insilico Medicine Details
10.2.2 Insilico Medicine Major Business
10.2.3 Insilico Medicine AI-Designed Small-Molecule Drugs Product and Services
10.2.4 Insilico Medicine AI-Designed Small-Molecule Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.2.5 Insilico Medicine Recent Developments/Updates
10.2.6 Insilico Medicine Competitive Strengths & Weaknesses
10.3 Schr?dinger
10.3.1 Schr?dinger Details
10.3.2 Schr?dinger Major Business
10.3.3 Schr?dinger AI-Designed Small-Molecule Drugs Product and Services
10.3.4 Schr?dinger AI-Designed Small-Molecule Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.3.5 Schr?dinger Recent Developments/Updates
10.3.6 Schr?dinger Competitive Strengths & Weaknesses
10.4 XtalPi
10.4.1 XtalPi Details
10.4.2 XtalPi Major Business
10.4.3 XtalPi AI-Designed Small-Molecule Drugs Product and Services
10.4.4 XtalPi AI-Designed Small-Molecule Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.4.5 XtalPi Recent Developments/Updates
10.4.6 XtalPi Competitive Strengths & Weaknesses
10.5 Isomorphic Labs
10.5.1 Isomorphic Labs Details
10.5.2 Isomorphic Labs Major Business
10.5.3 Isomorphic Labs AI-Designed Small-Molecule Drugs Product and Services
10.5.4 Isomorphic Labs AI-Designed Small-Molecule Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.5.5 Isomorphic Labs Recent Developments/Updates
10.5.6 Isomorphic Labs Competitive Strengths & Weaknesses
10.6 Relay Therapeutics
10.6.1 Relay Therapeutics Details
10.6.2 Relay Therapeutics Major Business
10.6.3 Relay Therapeutics AI-Designed Small-Molecule Drugs Product and Services
10.6.4 Relay Therapeutics AI-Designed Small-Molecule Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.6.5 Relay Therapeutics Recent Developments/Updates
10.6.6 Relay Therapeutics Competitive Strengths & Weaknesses
10.7 Nimbus Therapeutics
10.7.1 Nimbus Therapeutics Details
10.7.2 Nimbus Therapeutics Major Business
10.7.3 Nimbus Therapeutics AI-Designed Small-Molecule Drugs Product and Services
10.7.4 Nimbus Therapeutics AI-Designed Small-Molecule Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.7.5 Nimbus Therapeutics Recent Developments/Updates
10.7.6 Nimbus Therapeutics Competitive Strengths & Weaknesses
10.8 Iambic Therapeutics
10.8.1 Iambic Therapeutics Details
10.8.2 Iambic Therapeutics Major Business
10.8.3 Iambic Therapeutics AI-Designed Small-Molecule Drugs Product and Services
10.8.4 Iambic Therapeutics AI-Designed Small-Molecule Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.8.5 Iambic Therapeutics Recent Developments/Updates
10.8.6 Iambic Therapeutics Competitive Strengths & Weaknesses
10.9 BenevolentAI
10.9.1 BenevolentAI Details
10.9.2 BenevolentAI Major Business
10.9.3 BenevolentAI AI-Designed Small-Molecule Drugs Product and Services
10.9.4 BenevolentAI AI-Designed Small-Molecule Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.9.5 BenevolentAI Recent Developments/Updates
10.9.6 BenevolentAI Competitive Strengths & Weaknesses
10.10 Accutar Biotechnology
10.10.1 Accutar Biotechnology Details
10.10.2 Accutar Biotechnology Major Business
10.10.3 Accutar Biotechnology AI-Designed Small-Molecule Drugs Product and Services
10.10.4 Accutar Biotechnology AI-Designed Small-Molecule Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.10.5 Accutar Biotechnology Recent Developments/Updates
10.10.6 Accutar Biotechnology Competitive Strengths & Weaknesses
10.11 MindRank AI
10.11.1 MindRank AI Details
10.11.2 MindRank AI Major Business
10.11.3 MindRank AI AI-Designed Small-Molecule Drugs Product and Services
10.11.4 MindRank AI AI-Designed Small-Molecule Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.11.5 MindRank AI Recent Developments/Updates
10.11.6 MindRank AI Competitive Strengths & Weaknesses
10.12 Enveda Biosciences
10.12.1 Enveda Biosciences Details
10.12.2 Enveda Biosciences Major Business
10.12.3 Enveda Biosciences AI-Designed Small-Molecule Drugs Product and Services
10.12.4 Enveda Biosciences AI-Designed Small-Molecule Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.12.5 Enveda Biosciences Recent Developments/Updates
10.12.6 Enveda Biosciences Competitive Strengths & Weaknesses
10.13 Insitro
10.13.1 Insitro Details
10.13.2 Insitro Major Business
10.13.3 Insitro AI-Designed Small-Molecule Drugs Product and Services
10.13.4 Insitro AI-Designed Small-Molecule Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.13.5 Insitro Recent Developments/Updates
10.13.6 Insitro Competitive Strengths & Weaknesses
10.14 Valo Health
10.14.1 Valo Health Details
10.14.2 Valo Health Major Business
10.14.3 Valo Health AI-Designed Small-Molecule Drugs Product and Services
10.14.4 Valo Health AI-Designed Small-Molecule Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.14.5 Valo Health Recent Developments/Updates
10.14.6 Valo Health Competitive Strengths & Weaknesses
10.15 Healx
10.15.1 Healx Details
10.15.2 Healx Major Business
10.15.3 Healx AI-Designed Small-Molecule Drugs Product and Services
10.15.4 Healx AI-Designed Small-Molecule Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.15.5 Healx Recent Developments/Updates
10.15.6 Healx Competitive Strengths & Weaknesses
10.16 Lantern Pharma
10.16.1 Lantern Pharma Details
10.16.2 Lantern Pharma Major Business
10.16.3 Lantern Pharma AI-Designed Small-Molecule Drugs Product and Services
10.16.4 Lantern Pharma AI-Designed Small-Molecule Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.16.5 Lantern Pharma Recent Developments/Updates
10.16.6 Lantern Pharma Competitive Strengths & Weaknesses
10.17 Verge Labs
10.17.1 Verge Labs Details
10.17.2 Verge Labs Major Business
10.17.3 Verge Labs AI-Designed Small-Molecule Drugs Product and Services
10.17.4 Verge Labs AI-Designed Small-Molecule Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.17.5 Verge Labs Recent Developments/Updates
10.17.6 Verge Labs Competitive Strengths & Weaknesses
10.18 DeepCure
10.18.1 DeepCure Details
10.18.2 DeepCure Major Business
10.18.3 DeepCure AI-Designed Small-Molecule Drugs Product and Services
10.18.4 DeepCure AI-Designed Small-Molecule Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.18.5 DeepCure Recent Developments/Updates
10.18.6 DeepCure Competitive Strengths & Weaknesses
10.19 AQEMIA
10.19.1 AQEMIA Details
10.19.2 AQEMIA Major Business
10.19.3 AQEMIA AI-Designed Small-Molecule Drugs Product and Services
10.19.4 AQEMIA AI-Designed Small-Molecule Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.19.5 AQEMIA Recent Developments/Updates
10.19.6 AQEMIA Competitive Strengths & Weaknesses
10.20 Genesis Molecular AI
10.20.1 Genesis Molecular AI Details
10.20.2 Genesis Molecular AI Major Business
10.20.3 Genesis Molecular AI AI-Designed Small-Molecule Drugs Product and Services
10.20.4 Genesis Molecular AI AI-Designed Small-Molecule Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.20.5 Genesis Molecular AI Recent Developments/Updates
10.20.6 Genesis Molecular AI Competitive Strengths & Weaknesses
10.21 Terray Therapeutics
10.21.1 Terray Therapeutics Details
10.21.2 Terray Therapeutics Major Business
10.21.3 Terray Therapeutics AI-Designed Small-Molecule Drugs Product and Services
10.21.4 Terray Therapeutics AI-Designed Small-Molecule Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.21.5 Terray Therapeutics Recent Developments/Updates
10.21.6 Terray Therapeutics Competitive Strengths & Weaknesses
10.22 CHARM Therapeutics
10.22.1 CHARM Therapeutics Details
10.22.2 CHARM Therapeutics Major Business
10.22.3 CHARM Therapeutics AI-Designed Small-Molecule Drugs Product and Services
10.22.4 CHARM Therapeutics AI-Designed Small-Molecule Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.22.5 CHARM Therapeutics Recent Developments/Updates
10.22.6 CHARM Therapeutics Competitive Strengths & Weaknesses
10.23 Anagenex
10.23.1 Anagenex Details
10.23.2 Anagenex Major Business
10.23.3 Anagenex AI-Designed Small-Molecule Drugs Product and Services
10.23.4 Anagenex AI-Designed Small-Molecule Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.23.5 Anagenex Recent Developments/Updates
10.23.6 Anagenex Competitive Strengths & Weaknesses
10.24 StoneWise
10.24.1 StoneWise Details
10.24.2 StoneWise Major Business
10.24.3 StoneWise AI-Designed Small-Molecule Drugs Product and Services
10.24.4 StoneWise AI-Designed Small-Molecule Drugs Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.24.5 StoneWise Recent Developments/Updates
10.24.6 StoneWise Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 AI-Designed Small-Molecule Drugs Industry Chain
11.2 AI-Designed Small-Molecule Drugs Upstream Analysis
11.2.1 AI-Designed Small-Molecule Drugs Core Raw Materials
11.2.2 Main Manufacturers of AI-Designed Small-Molecule Drugs Core Raw Materials
11.3 Midstream Analysis
11.4 Downstream Analysis
11.5 AI-Designed Small-Molecule Drugs Production Mode
11.6 AI-Designed Small-Molecule Drugs Procurement Model
11.7 AI-Designed Small-Molecule Drugs Industry Sales Model and Sales Channels
11.7.1 AI-Designed Small-Molecule Drugs Sales Model
11.7.2 AI-Designed Small-Molecule Drugs Typical Distributors
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
LIST OF TABLES
Table 1. World AI-Designed Small-Molecule Drugs Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World AI-Designed Small-Molecule Drugs Production Value by Region (2021-2026) & (USD Million)
Table 3. World AI-Designed Small-Molecule Drugs Production Value by Region (2027-2032) & (USD Million)
Table 4. World AI-Designed Small-Molecule Drugs Production Value Market Share by Region (2021-2026)
Table 5. World AI-Designed Small-Molecule Drugs Production Value Market Share by Region (2027-2032)
Table 6. World AI-Designed Small-Molecule Drugs Production by Region (2021-2026) & (K Dose)
Table 7. World AI-Designed Small-Molecule Drugs Production by Region (2027-2032) & (K Dose)
Table 8. World AI-Designed Small-Molecule Drugs Production Market Share by Region (2021-2026)
Table 9. World AI-Designed Small-Molecule Drugs Production Market Share by Region (2027-2032)
Table 10. World AI-Designed Small-Molecule Drugs Average Price by Region (2021-2026) & (US$/Dose)
Table 11. World AI-Designed Small-Molecule Drugs Average Price by Region (2027-2032) & (US$/Dose)
Table 12. AI-Designed Small-Molecule Drugs Major Market Trends
Table 13. World AI-Designed Small-Molecule Drugs Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Dose)
Table 14. World AI-Designed Small-Molecule Drugs Consumption by Region (2021-2026) & (K Dose)
Table 15. World AI-Designed Small-Molecule Drugs Consumption Forecast by Region (2027-2032) & (K Dose)
Table 16. World AI-Designed Small-Molecule Drugs Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key AI-Designed Small-Molecule Drugs Producers in 2025
Table 18. World AI-Designed Small-Molecule Drugs Production by Manufacturer (2021-2026) & (K Dose)
Table 19. Production Market Share of Key AI-Designed Small-Molecule Drugs Producers in 2025
Table 20. World AI-Designed Small-Molecule Drugs Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 21. Global AI-Designed Small-Molecule Drugs Company Evaluation Quadrant
Table 22. World AI-Designed Small-Molecule Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and AI-Designed Small-Molecule Drugs Production Site of Key Manufacturer
Table 24. AI-Designed Small-Molecule Drugs Market: Company Product Type Footprint
Table 25. AI-Designed Small-Molecule Drugs Market: Company Product Application Footprint
Table 26. AI-Designed Small-Molecule Drugs Competitive Factors
Table 27. AI-Designed Small-Molecule Drugs New Entrant and Capacity Expansion Plans
Table 28. AI-Designed Small-Molecule Drugs Mergers & Acquisitions Activity
Table 29. United States VS China AI-Designed Small-Molecule Drugs Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China AI-Designed Small-Molecule Drugs Production Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 31. United States VS China AI-Designed Small-Molecule Drugs Consumption Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 32. United States Based AI-Designed Small-Molecule Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers AI-Designed Small-Molecule Drugs Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers AI-Designed Small-Molecule Drugs Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers AI-Designed Small-Molecule Drugs Production (2021-2026) & (K Dose)
Table 36. United States Based Manufacturers AI-Designed Small-Molecule Drugs Production Market Share (2021-2026)
Table 37. China Based AI-Designed Small-Molecule Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers AI-Designed Small-Molecule Drugs Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers AI-Designed Small-Molecule Drugs Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers AI-Designed Small-Molecule Drugs Production, (2021-2026) & (K Dose)
Table 41. China Based Manufacturers AI-Designed Small-Molecule Drugs Production Market Share (2021-2026)
Table 42. Rest of World Based AI-Designed Small-Molecule Drugs Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers AI-Designed Small-Molecule Drugs Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers AI-Designed Small-Molecule Drugs Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers AI-Designed Small-Molecule Drugs Production, (2021-2026) & (K Dose)
Table 46. Rest of World Based Manufacturers AI-Designed Small-Molecule Drugs Production Market Share (2021-2026)
Table 47. World AI-Designed Small-Molecule Drugs Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World AI-Designed Small-Molecule Drugs Production by Type (2021-2026) & (K Dose)
Table 49. World AI-Designed Small-Molecule Drugs Production by Type (2027-2032) & (K Dose)
Table 50. World AI-Designed Small-Molecule Drugs Production Value by Type (2021-2026) & (USD Million)
Table 51. World AI-Designed Small-Molecule Drugs Production Value by Type (2027-2032) & (USD Million)
Table 52. World AI-Designed Small-Molecule Drugs Average Price by Type (2021-2026) & (US$/Dose)
Table 53. World AI-Designed Small-Molecule Drugs Average Price by Type (2027-2032) & (US$/Dose)
Table 54. World AI-Designed Small-Molecule Drugs Production Value by Mechanism of Action, (USD Million), 2021 & 2025 & 2032
Table 55. World AI-Designed Small-Molecule Drugs Production by Mechanism of Action (2021-2026) & (K Dose)
Table 56. World AI-Designed Small-Molecule Drugs Production by Mechanism of Action (2027-2032) & (K Dose)
Table 57. World AI-Designed Small-Molecule Drugs Production Value by Mechanism of Action (2021-2026) & (USD Million)
Table 58. World AI-Designed Small-Molecule Drugs Production Value by Mechanism of Action (2027-2032) & (USD Million)
Table 59. World AI-Designed Small-Molecule Drugs Average Price by Mechanism of Action (2021-2026) & (US$/Dose)
Table 60. World AI-Designed Small-Molecule Drugs Average Price by Mechanism of Action (2027-2032) & (US$/Dose)
Table 61. World AI-Designed Small-Molecule Drugs Production Value by Route of Administration, (USD Million), 2021 & 2025 & 2032
Table 62. World AI-Designed Small-Molecule Drugs Production by Route of Administration (2021-2026) & (K Dose)
Table 63. World AI-Designed Small-Molecule Drugs Production by Route of Administration (2027-2032) & (K Dose)
Table 64. World AI-Designed Small-Molecule Drugs Production Value by Route of Administration (2021-2026) & (USD Million)
Table 65. World AI-Designed Small-Molecule Drugs Production Value by Route of Administration (2027-2032) & (USD Million)
Table 66. World AI-Designed Small-Molecule Drugs Average Price by Route of Administration (2021-2026) & (US$/Dose)
Table 67. World AI-Designed Small-Molecule Drugs Average Price by Route of Administration (2027-2032) & (US$/Dose)
Table 68. World AI-Designed Small-Molecule Drugs Production Value by Target Class, (USD Million), 2021 & 2025 & 2032
Table 69. World AI-Designed Small-Molecule Drugs Production by Target Class (2021-2026) & (K Dose)
Table 70. World AI-Designed Small-Molecule Drugs Production by Target Class (2027-2032) & (K Dose)
Table 71. World AI-Designed Small-Molecule Drugs Production Value by Target Class (2021-2026) & (USD Million)
Table 72. World AI-Designed Small-Molecule Drugs Production Value by Target Class (2027-2032) & (USD Million)
Table 73. World AI-Designed Small-Molecule Drugs Average Price by Target Class (2021-2026) & (US$/Dose)
Table 74. World AI-Designed Small-Molecule Drugs Average Price by Target Class (2027-2032) & (US$/Dose)
Table 75. World AI-Designed Small-Molecule Drugs Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 76. World AI-Designed Small-Molecule Drugs Production by Application (2021-2026) & (K Dose)
Table 77. World AI-Designed Small-Molecule Drugs Production by Application (2027-2032) & (K Dose)
Table 78. World AI-Designed Small-Molecule Drugs Production Value by Application (2021-2026) & (USD Million)
Table 79. World AI-Designed Small-Molecule Drugs Production Value by Application (2027-2032) & (USD Million)
Table 80. World AI-Designed Small-Molecule Drugs Average Price by Application (2021-2026) & (US$/Dose)
Table 81. World AI-Designed Small-Molecule Drugs Average Price by Application (2027-2032) & (US$/Dose)
Table 82. Recursion Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 83. Recursion Pharmaceuticals Major Business
Table 84. Recursion Pharmaceuticals AI-Designed Small-Molecule Drugs Product and Services
Table 85. Recursion Pharmaceuticals AI-Designed Small-Molecule Drugs Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 86. Recursion Pharmaceuticals Recent Developments/Updates
Table 87. Recursion Pharmaceuticals Competitive Strengths & Weaknesses
Table 88. Insilico Medicine Basic Information, Manufacturing Base and Competitors
Table 89. Insilico Medicine Major Business
Table 90. Insilico Medicine AI-Designed Small-Molecule Drugs Product and Services
Table 91. Insilico Medicine AI-Designed Small-Molecule Drugs Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 92. Insilico Medicine Recent Developments/Updates
Table 93. Insilico Medicine Competitive Strengths & Weaknesses
Table 94. Schr?dinger Basic Information, Manufacturing Base and Competitors
Table 95. Schr?dinger Major Business
Table 96. Schr?dinger AI-Designed Small-Molecule Drugs Product and Services
Table 97. Schr?dinger AI-Designed Small-Molecule Drugs Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 98. Schr?dinger Recent Developments/Updates
Table 99. Schr?dinger Competitive Strengths & Weaknesses
Table 100. XtalPi Basic Information, Manufacturing Base and Competitors
Table 101. XtalPi Major Business
Table 102. XtalPi AI-Designed Small-Molecule Drugs Product and Services
Table 103. XtalPi AI-Designed Small-Molecule Drugs Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 104. XtalPi Recent Developments/Updates
Table 105. XtalPi Competitive Strengths & Weaknesses
Table 106. Isomorphic Labs Basic Information, Manufacturing Base and Competitors
Table 107. Isomorphic Labs Major Business
Table 108. Isomorphic Labs AI-Designed Small-Molecule Drugs Product and Services
Table 109. Isomorphic Labs AI-Designed Small-Molecule Drugs Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 110. Isomorphic Labs Recent Developments/Updates
Table 111. Isomorphic Labs Competitive Strengths & Weaknesses
Table 112. Relay Therapeutics Basic Information, Manufacturing Base and Competitors
Table 113. Relay Therapeutics Major Business
Table 114. Relay Therapeutics AI-Designed Small-Molecule Drugs Product and Services
Table 115. Relay Therapeutics AI-Designed Small-Molecule Drugs Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 116. Relay Therapeutics Recent Developments/Updates
Table 117. Relay Therapeutics Competitive Strengths & Weaknesses
Table 118. Nimbus Therapeutics Basic Information, Manufacturing Base and Competitors
Table 119. Nimbus Therapeutics Major Business
Table 120. Nimbus Therapeutics AI-Designed Small-Molecule Drugs Product and Services
Table 121. Nimbus Therapeutics AI-Designed Small-Molecule Drugs Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 122. Nimbus Therapeutics Recent Developments/Updates
Table 123. Nimbus Therapeutics Competitive Strengths & Weaknesses
Table 124. Iambic Therapeutics Basic Information, Manufacturing Base and Competitors
Table 125. Iambic Therapeutics Major Business
Table 126. Iambic Therapeutics AI-Designed Small-Molecule Drugs Product and Services
Table 127. Iambic Therapeutics AI-Designed Small-Molecule Drugs Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 128. Iambic Therapeutics Recent Developments/Updates
Table 129. Iambic Therapeutics Competitive Strengths & Weaknesses
Table 130. BenevolentAI Basic Information, Manufacturing Base and Competitors
Table 131. BenevolentAI Major Business
Table 132. BenevolentAI AI-Designed Small-Molecule Drugs Product and Services
Table 133. BenevolentAI AI-Designed Small-Molecule Drugs Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 134. BenevolentAI Recent Developments/Updates
Table 135. BenevolentAI Competitive Strengths & Weaknesses
Table 136. Accutar Biotechnology Basic Information, Manufacturing Base and Competitors
Table 137. Accutar Biotechnology Major Business
Table 138. Accutar Biotechnology AI-Designed Small-Molecule Drugs Product and Services
Table 139. Accutar Biotechnology AI-Designed Small-Molecule Drugs Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 140. Accutar Biotechnology Recent Developments/Updates
Table 141. Accutar Biotechnology Competitive Strengths & Weaknesses
Table 142. MindRank AI Basic Information, Manufacturing Base and Competitors
Table 143. MindRank AI Major Business
Table 144. MindRank AI AI-Designed Small-Molecule Drugs Product and Services
Table 145. MindRank AI AI-Designed Small-Molecule Drugs Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 146. MindRank AI Recent Developments/Updates
Table 147. MindRank AI Competitive Strengths & Weaknesses
Table 148. Enveda Biosciences Basic Information, Manufacturing Base and Competitors
Table 149. Enveda Biosciences Major Business
Table 150. Enveda Biosciences AI-Designed Small-Molecule Drugs Product and Services
Table 151. Enveda Biosciences AI-Designed Small-Molecule Drugs Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 152. Enveda Biosciences Recent Developments/Updates
Table 153. Enveda Biosciences Competitive Strengths & Weaknesses
Table 154. Insitro Basic Information, Manufacturing Base and Competitors
Table 155. Insitro Major Business
Table 156. Insitro AI-Designed Small-Molecule Drugs Product and Services
Table 157. Insitro AI-Designed Small-Molecule Drugs Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 158. Insitro Recent Developments/Updates
Table 159. Insitro Competitive Strengths & Weaknesses
Table 160. Valo Health Basic Information, Manufacturing Base and Competitors
Table 161. Valo Health Major Business
Table 162. Valo Health AI-Designed Small-Molecule Drugs Product and Services
Table 163. Valo Health AI-Designed Small-Molecule Drugs Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 164. Valo Health Recent Developments/Updates
Table 165. Valo Health Competitive Strengths & Weaknesses
Table 166. Healx Basic Information, Manufacturing Base and Competitors
Table 167. Healx Major Business
Table 168. Healx AI-Designed Small-Molecule Drugs Product and Services
Table 169. Healx AI-Designed Small-Molecule Drugs Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 170. Healx Recent Developments/Updates
Table 171. Healx Competitive Strengths & Weaknesses
Table 172. Lantern Pharma Basic Information, Manufacturing Base and Competitors
Table 173. Lantern Pharma Major Business
Table 174. Lantern Pharma AI-Designed Small-Molecule Drugs Product and Services
Table 175. Lantern Pharma AI-Designed Small-Molecule Drugs Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 176. Lantern Pharma Recent Developments/Updates
Table 177. Lantern Pharma Competitive Strengths & Weaknesses
Table 178. Verge Labs Basic Information, Manufacturing Base and Competitors
Table 179. Verge Labs Major Business
Table 180. Verge Labs AI-Designed Small-Molecule Drugs Product and Services
Table 181. Verge Labs AI-Designed Small-Molecule Drugs Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 182. Verge Labs Recent Developments/Updates
Table 183. Verge Labs Competitive Strengths & Weaknesses
Table 184. DeepCure Basic Information, Manufacturing Base and Competitors
Table 185. DeepCure Major Business
Table 186. DeepCure AI-Designed Small-Molecule Drugs Product and Services
Table 187. DeepCure AI-Designed Small-Molecule Drugs Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 188. DeepCure Recent Developments/Updates
Table 189. DeepCure Competitive Strengths & Weaknesses
Table 190. AQEMIA Basic Information, Manufacturing Base and Competitors
Table 191. AQEMIA Major Business
Table 192. AQEMIA AI-Designed Small-Molecule Drugs Product and Services
Table 193. AQEMIA AI-Designed Small-Molecule Drugs Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 194. AQEMIA Recent Developments/Updates
Table 195. AQEMIA Competitive Strengths & Weaknesses
Table 196. Genesis Molecular AI Basic Information, Manufacturing Base and Competitors
Table 197. Genesis Molecular AI Major Business
Table 198. Genesis Molecular AI AI-Designed Small-Molecule Drugs Product and Services
Table 199. Genesis Molecular AI AI-Designed Small-Molecule Drugs Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 200. Genesis Molecular AI Recent Developments/Updates
Table 201. Genesis Molecular AI Competitive Strengths & Weaknesses
Table 202. Terray Therapeutics Basic Information, Manufacturing Base and Competitors
Table 203. Terray Therapeutics Major Business
Table 204. Terray Therapeutics AI-Designed Small-Molecule Drugs Product and Services
Table 205. Terray Therapeutics AI-Designed Small-Molecule Drugs Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 206. Terray Therapeutics Recent Developments/Updates
Table 207. Terray Therapeutics Competitive Strengths & Weaknesses
Table 208. CHARM Therapeutics Basic Information, Manufacturing Base and Competitors
Table 209. CHARM Therapeutics Major Business
Table 210. CHARM Therapeutics AI-Designed Small-Molecule Drugs Product and Services
Table 211. CHARM Therapeutics AI-Designed Small-Molecule Drugs Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 212. CHARM Therapeutics Recent Developments/Updates
Table 213. CHARM Therapeutics Competitive Strengths & Weaknesses
Table 214. Anagenex Basic Information, Manufacturing Base and Competitors
Table 215. Anagenex Major Business
Table 216. Anagenex AI-Designed Small-Molecule Drugs Product and Services
Table 217. Anagenex AI-Designed Small-Molecule Drugs Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 218. Anagenex Recent Developments/Updates
Table 219. Anagenex Competitive Strengths & Weaknesses
Table 220. StoneWise Basic Information, Manufacturing Base and Competitors
Table 221. StoneWise Major Business
Table 222. StoneWise AI-Designed Small-Molecule Drugs Product and Services
Table 223. StoneWise AI-Designed Small-Molecule Drugs Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 224. StoneWise Recent Developments/Updates
Table 225. StoneWise Competitive Strengths & Weaknesses
Table 226. Global Key Players of AI-Designed Small-Molecule Drugs Upstream (Raw Materials)
Table 227. Global AI-Designed Small-Molecule Drugs Typical Customers
Table 228. AI-Designed Small-Molecule Drugs Typical Distributors
Table 1. World AI-Designed Small-Molecule Drugs Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World AI-Designed Small-Molecule Drugs Production Value by Region (2021-2026) & (USD Million)
Table 3. World AI-Designed Small-Molecule Drugs Production Value by Region (2027-2032) & (USD Million)
Table 4. World AI-Designed Small-Molecule Drugs Production Value Market Share by Region (2021-2026)
Table 5. World AI-Designed Small-Molecule Drugs Production Value Market Share by Region (2027-2032)
Table 6. World AI-Designed Small-Molecule Drugs Production by Region (2021-2026) & (K Dose)
Table 7. World AI-Designed Small-Molecule Drugs Production by Region (2027-2032) & (K Dose)
Table 8. World AI-Designed Small-Molecule Drugs Production Market Share by Region (2021-2026)
Table 9. World AI-Designed Small-Molecule Drugs Production Market Share by Region (2027-2032)
Table 10. World AI-Designed Small-Molecule Drugs Average Price by Region (2021-2026) & (US$/Dose)
Table 11. World AI-Designed Small-Molecule Drugs Average Price by Region (2027-2032) & (US$/Dose)
Table 12. AI-Designed Small-Molecule Drugs Major Market Trends
Table 13. World AI-Designed Small-Molecule Drugs Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Dose)
Table 14. World AI-Designed Small-Molecule Drugs Consumption by Region (2021-2026) & (K Dose)
Table 15. World AI-Designed Small-Molecule Drugs Consumption Forecast by Region (2027-2032) & (K Dose)
Table 16. World AI-Designed Small-Molecule Drugs Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key AI-Designed Small-Molecule Drugs Producers in 2025
Table 18. World AI-Designed Small-Molecule Drugs Production by Manufacturer (2021-2026) & (K Dose)
Table 19. Production Market Share of Key AI-Designed Small-Molecule Drugs Producers in 2025
Table 20. World AI-Designed Small-Molecule Drugs Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 21. Global AI-Designed Small-Molecule Drugs Company Evaluation Quadrant
Table 22. World AI-Designed Small-Molecule Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and AI-Designed Small-Molecule Drugs Production Site of Key Manufacturer
Table 24. AI-Designed Small-Molecule Drugs Market: Company Product Type Footprint
Table 25. AI-Designed Small-Molecule Drugs Market: Company Product Application Footprint
Table 26. AI-Designed Small-Molecule Drugs Competitive Factors
Table 27. AI-Designed Small-Molecule Drugs New Entrant and Capacity Expansion Plans
Table 28. AI-Designed Small-Molecule Drugs Mergers & Acquisitions Activity
Table 29. United States VS China AI-Designed Small-Molecule Drugs Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China AI-Designed Small-Molecule Drugs Production Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 31. United States VS China AI-Designed Small-Molecule Drugs Consumption Comparison, (2021 & 2025 & 2032) & (K Dose)
Table 32. United States Based AI-Designed Small-Molecule Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers AI-Designed Small-Molecule Drugs Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers AI-Designed Small-Molecule Drugs Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers AI-Designed Small-Molecule Drugs Production (2021-2026) & (K Dose)
Table 36. United States Based Manufacturers AI-Designed Small-Molecule Drugs Production Market Share (2021-2026)
Table 37. China Based AI-Designed Small-Molecule Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers AI-Designed Small-Molecule Drugs Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers AI-Designed Small-Molecule Drugs Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers AI-Designed Small-Molecule Drugs Production, (2021-2026) & (K Dose)
Table 41. China Based Manufacturers AI-Designed Small-Molecule Drugs Production Market Share (2021-2026)
Table 42. Rest of World Based AI-Designed Small-Molecule Drugs Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers AI-Designed Small-Molecule Drugs Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers AI-Designed Small-Molecule Drugs Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers AI-Designed Small-Molecule Drugs Production, (2021-2026) & (K Dose)
Table 46. Rest of World Based Manufacturers AI-Designed Small-Molecule Drugs Production Market Share (2021-2026)
Table 47. World AI-Designed Small-Molecule Drugs Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World AI-Designed Small-Molecule Drugs Production by Type (2021-2026) & (K Dose)
Table 49. World AI-Designed Small-Molecule Drugs Production by Type (2027-2032) & (K Dose)
Table 50. World AI-Designed Small-Molecule Drugs Production Value by Type (2021-2026) & (USD Million)
Table 51. World AI-Designed Small-Molecule Drugs Production Value by Type (2027-2032) & (USD Million)
Table 52. World AI-Designed Small-Molecule Drugs Average Price by Type (2021-2026) & (US$/Dose)
Table 53. World AI-Designed Small-Molecule Drugs Average Price by Type (2027-2032) & (US$/Dose)
Table 54. World AI-Designed Small-Molecule Drugs Production Value by Mechanism of Action, (USD Million), 2021 & 2025 & 2032
Table 55. World AI-Designed Small-Molecule Drugs Production by Mechanism of Action (2021-2026) & (K Dose)
Table 56. World AI-Designed Small-Molecule Drugs Production by Mechanism of Action (2027-2032) & (K Dose)
Table 57. World AI-Designed Small-Molecule Drugs Production Value by Mechanism of Action (2021-2026) & (USD Million)
Table 58. World AI-Designed Small-Molecule Drugs Production Value by Mechanism of Action (2027-2032) & (USD Million)
Table 59. World AI-Designed Small-Molecule Drugs Average Price by Mechanism of Action (2021-2026) & (US$/Dose)
Table 60. World AI-Designed Small-Molecule Drugs Average Price by Mechanism of Action (2027-2032) & (US$/Dose)
Table 61. World AI-Designed Small-Molecule Drugs Production Value by Route of Administration, (USD Million), 2021 & 2025 & 2032
Table 62. World AI-Designed Small-Molecule Drugs Production by Route of Administration (2021-2026) & (K Dose)
Table 63. World AI-Designed Small-Molecule Drugs Production by Route of Administration (2027-2032) & (K Dose)
Table 64. World AI-Designed Small-Molecule Drugs Production Value by Route of Administration (2021-2026) & (USD Million)
Table 65. World AI-Designed Small-Molecule Drugs Production Value by Route of Administration (2027-2032) & (USD Million)
Table 66. World AI-Designed Small-Molecule Drugs Average Price by Route of Administration (2021-2026) & (US$/Dose)
Table 67. World AI-Designed Small-Molecule Drugs Average Price by Route of Administration (2027-2032) & (US$/Dose)
Table 68. World AI-Designed Small-Molecule Drugs Production Value by Target Class, (USD Million), 2021 & 2025 & 2032
Table 69. World AI-Designed Small-Molecule Drugs Production by Target Class (2021-2026) & (K Dose)
Table 70. World AI-Designed Small-Molecule Drugs Production by Target Class (2027-2032) & (K Dose)
Table 71. World AI-Designed Small-Molecule Drugs Production Value by Target Class (2021-2026) & (USD Million)
Table 72. World AI-Designed Small-Molecule Drugs Production Value by Target Class (2027-2032) & (USD Million)
Table 73. World AI-Designed Small-Molecule Drugs Average Price by Target Class (2021-2026) & (US$/Dose)
Table 74. World AI-Designed Small-Molecule Drugs Average Price by Target Class (2027-2032) & (US$/Dose)
Table 75. World AI-Designed Small-Molecule Drugs Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 76. World AI-Designed Small-Molecule Drugs Production by Application (2021-2026) & (K Dose)
Table 77. World AI-Designed Small-Molecule Drugs Production by Application (2027-2032) & (K Dose)
Table 78. World AI-Designed Small-Molecule Drugs Production Value by Application (2021-2026) & (USD Million)
Table 79. World AI-Designed Small-Molecule Drugs Production Value by Application (2027-2032) & (USD Million)
Table 80. World AI-Designed Small-Molecule Drugs Average Price by Application (2021-2026) & (US$/Dose)
Table 81. World AI-Designed Small-Molecule Drugs Average Price by Application (2027-2032) & (US$/Dose)
Table 82. Recursion Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 83. Recursion Pharmaceuticals Major Business
Table 84. Recursion Pharmaceuticals AI-Designed Small-Molecule Drugs Product and Services
Table 85. Recursion Pharmaceuticals AI-Designed Small-Molecule Drugs Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 86. Recursion Pharmaceuticals Recent Developments/Updates
Table 87. Recursion Pharmaceuticals Competitive Strengths & Weaknesses
Table 88. Insilico Medicine Basic Information, Manufacturing Base and Competitors
Table 89. Insilico Medicine Major Business
Table 90. Insilico Medicine AI-Designed Small-Molecule Drugs Product and Services
Table 91. Insilico Medicine AI-Designed Small-Molecule Drugs Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 92. Insilico Medicine Recent Developments/Updates
Table 93. Insilico Medicine Competitive Strengths & Weaknesses
Table 94. Schr?dinger Basic Information, Manufacturing Base and Competitors
Table 95. Schr?dinger Major Business
Table 96. Schr?dinger AI-Designed Small-Molecule Drugs Product and Services
Table 97. Schr?dinger AI-Designed Small-Molecule Drugs Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 98. Schr?dinger Recent Developments/Updates
Table 99. Schr?dinger Competitive Strengths & Weaknesses
Table 100. XtalPi Basic Information, Manufacturing Base and Competitors
Table 101. XtalPi Major Business
Table 102. XtalPi AI-Designed Small-Molecule Drugs Product and Services
Table 103. XtalPi AI-Designed Small-Molecule Drugs Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 104. XtalPi Recent Developments/Updates
Table 105. XtalPi Competitive Strengths & Weaknesses
Table 106. Isomorphic Labs Basic Information, Manufacturing Base and Competitors
Table 107. Isomorphic Labs Major Business
Table 108. Isomorphic Labs AI-Designed Small-Molecule Drugs Product and Services
Table 109. Isomorphic Labs AI-Designed Small-Molecule Drugs Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 110. Isomorphic Labs Recent Developments/Updates
Table 111. Isomorphic Labs Competitive Strengths & Weaknesses
Table 112. Relay Therapeutics Basic Information, Manufacturing Base and Competitors
Table 113. Relay Therapeutics Major Business
Table 114. Relay Therapeutics AI-Designed Small-Molecule Drugs Product and Services
Table 115. Relay Therapeutics AI-Designed Small-Molecule Drugs Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 116. Relay Therapeutics Recent Developments/Updates
Table 117. Relay Therapeutics Competitive Strengths & Weaknesses
Table 118. Nimbus Therapeutics Basic Information, Manufacturing Base and Competitors
Table 119. Nimbus Therapeutics Major Business
Table 120. Nimbus Therapeutics AI-Designed Small-Molecule Drugs Product and Services
Table 121. Nimbus Therapeutics AI-Designed Small-Molecule Drugs Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 122. Nimbus Therapeutics Recent Developments/Updates
Table 123. Nimbus Therapeutics Competitive Strengths & Weaknesses
Table 124. Iambic Therapeutics Basic Information, Manufacturing Base and Competitors
Table 125. Iambic Therapeutics Major Business
Table 126. Iambic Therapeutics AI-Designed Small-Molecule Drugs Product and Services
Table 127. Iambic Therapeutics AI-Designed Small-Molecule Drugs Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 128. Iambic Therapeutics Recent Developments/Updates
Table 129. Iambic Therapeutics Competitive Strengths & Weaknesses
Table 130. BenevolentAI Basic Information, Manufacturing Base and Competitors
Table 131. BenevolentAI Major Business
Table 132. BenevolentAI AI-Designed Small-Molecule Drugs Product and Services
Table 133. BenevolentAI AI-Designed Small-Molecule Drugs Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 134. BenevolentAI Recent Developments/Updates
Table 135. BenevolentAI Competitive Strengths & Weaknesses
Table 136. Accutar Biotechnology Basic Information, Manufacturing Base and Competitors
Table 137. Accutar Biotechnology Major Business
Table 138. Accutar Biotechnology AI-Designed Small-Molecule Drugs Product and Services
Table 139. Accutar Biotechnology AI-Designed Small-Molecule Drugs Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 140. Accutar Biotechnology Recent Developments/Updates
Table 141. Accutar Biotechnology Competitive Strengths & Weaknesses
Table 142. MindRank AI Basic Information, Manufacturing Base and Competitors
Table 143. MindRank AI Major Business
Table 144. MindRank AI AI-Designed Small-Molecule Drugs Product and Services
Table 145. MindRank AI AI-Designed Small-Molecule Drugs Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 146. MindRank AI Recent Developments/Updates
Table 147. MindRank AI Competitive Strengths & Weaknesses
Table 148. Enveda Biosciences Basic Information, Manufacturing Base and Competitors
Table 149. Enveda Biosciences Major Business
Table 150. Enveda Biosciences AI-Designed Small-Molecule Drugs Product and Services
Table 151. Enveda Biosciences AI-Designed Small-Molecule Drugs Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 152. Enveda Biosciences Recent Developments/Updates
Table 153. Enveda Biosciences Competitive Strengths & Weaknesses
Table 154. Insitro Basic Information, Manufacturing Base and Competitors
Table 155. Insitro Major Business
Table 156. Insitro AI-Designed Small-Molecule Drugs Product and Services
Table 157. Insitro AI-Designed Small-Molecule Drugs Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 158. Insitro Recent Developments/Updates
Table 159. Insitro Competitive Strengths & Weaknesses
Table 160. Valo Health Basic Information, Manufacturing Base and Competitors
Table 161. Valo Health Major Business
Table 162. Valo Health AI-Designed Small-Molecule Drugs Product and Services
Table 163. Valo Health AI-Designed Small-Molecule Drugs Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 164. Valo Health Recent Developments/Updates
Table 165. Valo Health Competitive Strengths & Weaknesses
Table 166. Healx Basic Information, Manufacturing Base and Competitors
Table 167. Healx Major Business
Table 168. Healx AI-Designed Small-Molecule Drugs Product and Services
Table 169. Healx AI-Designed Small-Molecule Drugs Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 170. Healx Recent Developments/Updates
Table 171. Healx Competitive Strengths & Weaknesses
Table 172. Lantern Pharma Basic Information, Manufacturing Base and Competitors
Table 173. Lantern Pharma Major Business
Table 174. Lantern Pharma AI-Designed Small-Molecule Drugs Product and Services
Table 175. Lantern Pharma AI-Designed Small-Molecule Drugs Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 176. Lantern Pharma Recent Developments/Updates
Table 177. Lantern Pharma Competitive Strengths & Weaknesses
Table 178. Verge Labs Basic Information, Manufacturing Base and Competitors
Table 179. Verge Labs Major Business
Table 180. Verge Labs AI-Designed Small-Molecule Drugs Product and Services
Table 181. Verge Labs AI-Designed Small-Molecule Drugs Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 182. Verge Labs Recent Developments/Updates
Table 183. Verge Labs Competitive Strengths & Weaknesses
Table 184. DeepCure Basic Information, Manufacturing Base and Competitors
Table 185. DeepCure Major Business
Table 186. DeepCure AI-Designed Small-Molecule Drugs Product and Services
Table 187. DeepCure AI-Designed Small-Molecule Drugs Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 188. DeepCure Recent Developments/Updates
Table 189. DeepCure Competitive Strengths & Weaknesses
Table 190. AQEMIA Basic Information, Manufacturing Base and Competitors
Table 191. AQEMIA Major Business
Table 192. AQEMIA AI-Designed Small-Molecule Drugs Product and Services
Table 193. AQEMIA AI-Designed Small-Molecule Drugs Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 194. AQEMIA Recent Developments/Updates
Table 195. AQEMIA Competitive Strengths & Weaknesses
Table 196. Genesis Molecular AI Basic Information, Manufacturing Base and Competitors
Table 197. Genesis Molecular AI Major Business
Table 198. Genesis Molecular AI AI-Designed Small-Molecule Drugs Product and Services
Table 199. Genesis Molecular AI AI-Designed Small-Molecule Drugs Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 200. Genesis Molecular AI Recent Developments/Updates
Table 201. Genesis Molecular AI Competitive Strengths & Weaknesses
Table 202. Terray Therapeutics Basic Information, Manufacturing Base and Competitors
Table 203. Terray Therapeutics Major Business
Table 204. Terray Therapeutics AI-Designed Small-Molecule Drugs Product and Services
Table 205. Terray Therapeutics AI-Designed Small-Molecule Drugs Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 206. Terray Therapeutics Recent Developments/Updates
Table 207. Terray Therapeutics Competitive Strengths & Weaknesses
Table 208. CHARM Therapeutics Basic Information, Manufacturing Base and Competitors
Table 209. CHARM Therapeutics Major Business
Table 210. CHARM Therapeutics AI-Designed Small-Molecule Drugs Product and Services
Table 211. CHARM Therapeutics AI-Designed Small-Molecule Drugs Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 212. CHARM Therapeutics Recent Developments/Updates
Table 213. CHARM Therapeutics Competitive Strengths & Weaknesses
Table 214. Anagenex Basic Information, Manufacturing Base and Competitors
Table 215. Anagenex Major Business
Table 216. Anagenex AI-Designed Small-Molecule Drugs Product and Services
Table 217. Anagenex AI-Designed Small-Molecule Drugs Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 218. Anagenex Recent Developments/Updates
Table 219. Anagenex Competitive Strengths & Weaknesses
Table 220. StoneWise Basic Information, Manufacturing Base and Competitors
Table 221. StoneWise Major Business
Table 222. StoneWise AI-Designed Small-Molecule Drugs Product and Services
Table 223. StoneWise AI-Designed Small-Molecule Drugs Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 224. StoneWise Recent Developments/Updates
Table 225. StoneWise Competitive Strengths & Weaknesses
Table 226. Global Key Players of AI-Designed Small-Molecule Drugs Upstream (Raw Materials)
Table 227. Global AI-Designed Small-Molecule Drugs Typical Customers
Table 228. AI-Designed Small-Molecule Drugs Typical Distributors
LIST OF FIGURES
Figure 1. AI-Designed Small-Molecule Drugs Picture
Figure 2. World AI-Designed Small-Molecule Drugs Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World AI-Designed Small-Molecule Drugs Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World AI-Designed Small-Molecule Drugs Production (2021-2032) & (K Dose)
Figure 5. World AI-Designed Small-Molecule Drugs Average Price (2021-2032) & (US$/Dose)
Figure 6. World AI-Designed Small-Molecule Drugs Production Value Market Share by Region (2021-2032)
Figure 7. World AI-Designed Small-Molecule Drugs Production Market Share by Region (2021-2032)
Figure 8. North America AI-Designed Small-Molecule Drugs Production (2021-2032) & (K Dose)
Figure 9. Europe AI-Designed Small-Molecule Drugs Production (2021-2032) & (K Dose)
Figure 10. China AI-Designed Small-Molecule Drugs Production (2021-2032) & (K Dose)
Figure 11. Japan AI-Designed Small-Molecule Drugs Production (2021-2032) & (K Dose)
Figure 12. India AI-Designed Small-Molecule Drugs Production (2021-2032) & (K Dose)
Figure 13. AI-Designed Small-Molecule Drugs Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World AI-Designed Small-Molecule Drugs Consumption (2021-2032) & (K Dose)
Figure 16. World AI-Designed Small-Molecule Drugs Consumption Market Share by Region (2021-2032)
Figure 17. United States AI-Designed Small-Molecule Drugs Consumption (2021-2032) & (K Dose)
Figure 18. China AI-Designed Small-Molecule Drugs Consumption (2021-2032) & (K Dose)
Figure 19. Europe AI-Designed Small-Molecule Drugs Consumption (2021-2032) & (K Dose)
Figure 20. Japan AI-Designed Small-Molecule Drugs Consumption (2021-2032) & (K Dose)
Figure 21. South Korea AI-Designed Small-Molecule Drugs Consumption (2021-2032) & (K Dose)
Figure 22. ASEAN AI-Designed Small-Molecule Drugs Consumption (2021-2032) & (K Dose)
Figure 23. India AI-Designed Small-Molecule Drugs Consumption (2021-2032) & (K Dose)
Figure 24. Producer Shipments of AI-Designed Small-Molecule Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for AI-Designed Small-Molecule Drugs Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for AI-Designed Small-Molecule Drugs Markets in 2025
Figure 27. United States VS China: AI-Designed Small-Molecule Drugs Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: AI-Designed Small-Molecule Drugs Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: AI-Designed Small-Molecule Drugs Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers AI-Designed Small-Molecule Drugs Production Market Share 2025
Figure 31. China Based Manufacturers AI-Designed Small-Molecule Drugs Production Market Share 2025
Figure 32. Rest of World Based Manufacturers AI-Designed Small-Molecule Drugs Production Market Share 2025
Figure 33. World AI-Designed Small-Molecule Drugs Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World AI-Designed Small-Molecule Drugs Production Value Market Share by Type in 2025
Figure 35. Discovery-Stage Candidates
Figure 36. Preclinical Candidates
Figure 37. Clinical-Stage Candidates
Figure 38. Approved Drugs
Figure 39. World AI-Designed Small-Molecule Drugs Production Market Share by Type (2021-2032)
Figure 40. World AI-Designed Small-Molecule Drugs Production Value Market Share by Type (2021-2032)
Figure 41. World AI-Designed Small-Molecule Drugs Average Price by Type (2021-2032) & (US$/Dose)
Figure 42. World AI-Designed Small-Molecule Drugs Production Value by Mechanism of Action, (USD Million), 2021 & 2025 & 2032
Figure 43. World AI-Designed Small-Molecule Drugs Production Value Market Share by Mechanism of Action in 2025
Figure 44. Enzyme Inhibitors
Figure 45. Receptor Agonists
Figure 46. Receptor Antagonists
Figure 47. Targeted Protein Degraders
Figure 48. Molecular Glues
Figure 49. Other Small-Molecule Modulators
Figure 50. World AI-Designed Small-Molecule Drugs Production Market Share by Mechanism of Action (2021-2032)
Figure 51. World AI-Designed Small-Molecule Drugs Production Value Market Share by Mechanism of Action (2021-2032)
Figure 52. World AI-Designed Small-Molecule Drugs Average Price by Mechanism of Action (2021-2032) & (US$/Dose)
Figure 53. World AI-Designed Small-Molecule Drugs Production Value by Route of Administration, (USD Million), 2021 & 2025 & 2032
Figure 54. World AI-Designed Small-Molecule Drugs Production Value Market Share by Route of Administration in 2025
Figure 55. Oral Drugs
Figure 56. Injectable Drugs
Figure 57. Inhaled Drugs
Figure 58. Topical Drugs
Figure 59. Other Administration Routes
Figure 60. World AI-Designed Small-Molecule Drugs Production Market Share by Route of Administration (2021-2032)
Figure 61. World AI-Designed Small-Molecule Drugs Production Value Market Share by Route of Administration (2021-2032)
Figure 62. World AI-Designed Small-Molecule Drugs Average Price by Route of Administration (2021-2032) & (US$/Dose)
Figure 63. World AI-Designed Small-Molecule Drugs Production Value by Target Class, (USD Million), 2021 & 2025 & 2032
Figure 64. World AI-Designed Small-Molecule Drugs Production Value Market Share by Target Class in 2025
Figure 65. Kinases
Figure 66. Other Enzymes
Figure 67. G Protein-Coupled Receptors
Figure 68. Nuclear Receptors
Figure 69. Protein?Protein Interaction Targets
Figure 70. Nucleic Acid Targets
Figure 71. Other Target Classes
Figure 72. Other Target Classes
Figure 73. World AI-Designed Small-Molecule Drugs Production Market Share by Target Class (2021-2032)
Figure 74. World AI-Designed Small-Molecule Drugs Production Value Market Share by Target Class (2021-2032)
Figure 75. World AI-Designed Small-Molecule Drugs Average Price by Target Class (2021-2032) & (US$/Dose)
Figure 76. World AI-Designed Small-Molecule Drugs Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 77. World AI-Designed Small-Molecule Drugs Production Value Market Share by Application in 2025
Figure 78. Oncology
Figure 79. Immunology and Inflammation
Figure 80. Neurology and Psychiatry
Figure 81. Metabolic and Cardiovascular Diseases
Figure 82. Infectious Diseases
Figure 83. Other Therapeutic Areas
Figure 84. World AI-Designed Small-Molecule Drugs Production Market Share by Application (2021-2032)
Figure 85. World AI-Designed Small-Molecule Drugs Production Value Market Share by Application (2021-2032)
Figure 86. World AI-Designed Small-Molecule Drugs Average Price by Application (2021-2032) & (US$/Dose)
Figure 87. AI-Designed Small-Molecule Drugs Industry Chain
Figure 88. AI-Designed Small-Molecule Drugs Procurement Model
Figure 89. AI-Designed Small-Molecule Drugs Sales Model
Figure 90. AI-Designed Small-Molecule Drugs Sales Channels, Direct Sales, and Distribution
Figure 91. Methodology
Figure 92. Research Process and Data Source
Figure 1. AI-Designed Small-Molecule Drugs Picture
Figure 2. World AI-Designed Small-Molecule Drugs Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World AI-Designed Small-Molecule Drugs Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World AI-Designed Small-Molecule Drugs Production (2021-2032) & (K Dose)
Figure 5. World AI-Designed Small-Molecule Drugs Average Price (2021-2032) & (US$/Dose)
Figure 6. World AI-Designed Small-Molecule Drugs Production Value Market Share by Region (2021-2032)
Figure 7. World AI-Designed Small-Molecule Drugs Production Market Share by Region (2021-2032)
Figure 8. North America AI-Designed Small-Molecule Drugs Production (2021-2032) & (K Dose)
Figure 9. Europe AI-Designed Small-Molecule Drugs Production (2021-2032) & (K Dose)
Figure 10. China AI-Designed Small-Molecule Drugs Production (2021-2032) & (K Dose)
Figure 11. Japan AI-Designed Small-Molecule Drugs Production (2021-2032) & (K Dose)
Figure 12. India AI-Designed Small-Molecule Drugs Production (2021-2032) & (K Dose)
Figure 13. AI-Designed Small-Molecule Drugs Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World AI-Designed Small-Molecule Drugs Consumption (2021-2032) & (K Dose)
Figure 16. World AI-Designed Small-Molecule Drugs Consumption Market Share by Region (2021-2032)
Figure 17. United States AI-Designed Small-Molecule Drugs Consumption (2021-2032) & (K Dose)
Figure 18. China AI-Designed Small-Molecule Drugs Consumption (2021-2032) & (K Dose)
Figure 19. Europe AI-Designed Small-Molecule Drugs Consumption (2021-2032) & (K Dose)
Figure 20. Japan AI-Designed Small-Molecule Drugs Consumption (2021-2032) & (K Dose)
Figure 21. South Korea AI-Designed Small-Molecule Drugs Consumption (2021-2032) & (K Dose)
Figure 22. ASEAN AI-Designed Small-Molecule Drugs Consumption (2021-2032) & (K Dose)
Figure 23. India AI-Designed Small-Molecule Drugs Consumption (2021-2032) & (K Dose)
Figure 24. Producer Shipments of AI-Designed Small-Molecule Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for AI-Designed Small-Molecule Drugs Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for AI-Designed Small-Molecule Drugs Markets in 2025
Figure 27. United States VS China: AI-Designed Small-Molecule Drugs Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: AI-Designed Small-Molecule Drugs Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: AI-Designed Small-Molecule Drugs Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers AI-Designed Small-Molecule Drugs Production Market Share 2025
Figure 31. China Based Manufacturers AI-Designed Small-Molecule Drugs Production Market Share 2025
Figure 32. Rest of World Based Manufacturers AI-Designed Small-Molecule Drugs Production Market Share 2025
Figure 33. World AI-Designed Small-Molecule Drugs Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World AI-Designed Small-Molecule Drugs Production Value Market Share by Type in 2025
Figure 35. Discovery-Stage Candidates
Figure 36. Preclinical Candidates
Figure 37. Clinical-Stage Candidates
Figure 38. Approved Drugs
Figure 39. World AI-Designed Small-Molecule Drugs Production Market Share by Type (2021-2032)
Figure 40. World AI-Designed Small-Molecule Drugs Production Value Market Share by Type (2021-2032)
Figure 41. World AI-Designed Small-Molecule Drugs Average Price by Type (2021-2032) & (US$/Dose)
Figure 42. World AI-Designed Small-Molecule Drugs Production Value by Mechanism of Action, (USD Million), 2021 & 2025 & 2032
Figure 43. World AI-Designed Small-Molecule Drugs Production Value Market Share by Mechanism of Action in 2025
Figure 44. Enzyme Inhibitors
Figure 45. Receptor Agonists
Figure 46. Receptor Antagonists
Figure 47. Targeted Protein Degraders
Figure 48. Molecular Glues
Figure 49. Other Small-Molecule Modulators
Figure 50. World AI-Designed Small-Molecule Drugs Production Market Share by Mechanism of Action (2021-2032)
Figure 51. World AI-Designed Small-Molecule Drugs Production Value Market Share by Mechanism of Action (2021-2032)
Figure 52. World AI-Designed Small-Molecule Drugs Average Price by Mechanism of Action (2021-2032) & (US$/Dose)
Figure 53. World AI-Designed Small-Molecule Drugs Production Value by Route of Administration, (USD Million), 2021 & 2025 & 2032
Figure 54. World AI-Designed Small-Molecule Drugs Production Value Market Share by Route of Administration in 2025
Figure 55. Oral Drugs
Figure 56. Injectable Drugs
Figure 57. Inhaled Drugs
Figure 58. Topical Drugs
Figure 59. Other Administration Routes
Figure 60. World AI-Designed Small-Molecule Drugs Production Market Share by Route of Administration (2021-2032)
Figure 61. World AI-Designed Small-Molecule Drugs Production Value Market Share by Route of Administration (2021-2032)
Figure 62. World AI-Designed Small-Molecule Drugs Average Price by Route of Administration (2021-2032) & (US$/Dose)
Figure 63. World AI-Designed Small-Molecule Drugs Production Value by Target Class, (USD Million), 2021 & 2025 & 2032
Figure 64. World AI-Designed Small-Molecule Drugs Production Value Market Share by Target Class in 2025
Figure 65. Kinases
Figure 66. Other Enzymes
Figure 67. G Protein-Coupled Receptors
Figure 68. Nuclear Receptors
Figure 69. Protein?Protein Interaction Targets
Figure 70. Nucleic Acid Targets
Figure 71. Other Target Classes
Figure 72. Other Target Classes
Figure 73. World AI-Designed Small-Molecule Drugs Production Market Share by Target Class (2021-2032)
Figure 74. World AI-Designed Small-Molecule Drugs Production Value Market Share by Target Class (2021-2032)
Figure 75. World AI-Designed Small-Molecule Drugs Average Price by Target Class (2021-2032) & (US$/Dose)
Figure 76. World AI-Designed Small-Molecule Drugs Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 77. World AI-Designed Small-Molecule Drugs Production Value Market Share by Application in 2025
Figure 78. Oncology
Figure 79. Immunology and Inflammation
Figure 80. Neurology and Psychiatry
Figure 81. Metabolic and Cardiovascular Diseases
Figure 82. Infectious Diseases
Figure 83. Other Therapeutic Areas
Figure 84. World AI-Designed Small-Molecule Drugs Production Market Share by Application (2021-2032)
Figure 85. World AI-Designed Small-Molecule Drugs Production Value Market Share by Application (2021-2032)
Figure 86. World AI-Designed Small-Molecule Drugs Average Price by Application (2021-2032) & (US$/Dose)
Figure 87. AI-Designed Small-Molecule Drugs Industry Chain
Figure 88. AI-Designed Small-Molecule Drugs Procurement Model
Figure 89. AI-Designed Small-Molecule Drugs Sales Model
Figure 90. AI-Designed Small-Molecule Drugs Sales Channels, Direct Sales, and Distribution
Figure 91. Methodology
Figure 92. Research Process and Data Source
